LAUSANNE, Switzerland – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, announced today that it has completed CHF 40M in Series D1 funding. The round was led by Ernst-Göhner Stiftung Beteiligungen (EGSB), and existing investors PHC Holdings Corporation, Swiss Entrepreneurs Fund, OCCIDENT, and Redalpine participated. The funding includes a EUR […]
AMSBIO is pleased to announce the launch of Extragel, a like-for-like replacement for Matrigel™, GeltrexTM and CultrexTM Basement Membrane Extract (BME). Available ex-stock, with overnight shipment, Extragel is a reconstituted matrix hydrogel formed by basement membrane components extracted from mouse tumor tissues which are rich in extracellular matrix proteins. Designed to be used undiluted or diluted to a specific protein concentration, Extragel is proven to […]
PhenomeX to begin trading under symbol (NASDAQ: CELL) EMERYVILLE, Calif. — Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health. The newly combined […]
Appoints Dr. Yan Zhang as Chief Commercial Officer Tomoya Aoyama to Lead Commercial Operations in APAC EMERYVILLE, Calif. — PhenomeX (Nasdaq: CELL), the functional cell biology company, today announced that Yan Zhang, Ph.D., has been named chief commercial officer (CCO), effective immediately. In addition to Dr. Zhang’s appointment, PhenomeX also announced that Tomoya Aoyama has been named Regional […]
Joe Driscoll to Retire After More than Four Successful Years as Chief Financial Officer Johnny Ek Appointed as new Chief Financial Officer MARLBOROUGH, Mass. — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Chief Financial Officer Joe Driscoll is retiring from his position, effective March 20, 2023. Johnny Ek has […]
Researchers can now access over 8,000 patient-derived xenografts (PDX), cell-derived xenografts (CDX), organoids and cell lines from Scientist.com’s AI-powered Disease Model Finder SAN DIEGO — Scientist.com, the premier R&D marketplace for the biopharmaceutical industry, announced today that it has partnered with leading contract research organizations (CROs), including Crown Bioscience, Imagen Therapeutics and Experimental Pharmacology & Oncology Berlin-Buch (EPO) to boost […]
Significant value unlocked for Enzo shareholders with continued focus on remaining businesses. FARMINGDALE, NY — Enzo Biochem, Inc. (NYSE:ENZ) announced today that it has entered into an agreement for Labcorp (NYSE: LH) to acquire the assets of Enzo’s Clinical Laboratory division (Enzo Clinical Labs). The transaction between two leading global life sciences companies follows several […]
SAN FRANCISCO, CA —Tempo Bioscience, Inc. (“Tempo”) a privately-held biotechnology company based in San Francisco, California, has released new human induced pluripotent stem cell (iPSC) derived cell products and affiliated cell-based services in the following categories: Tempo-iHepStellate™ – Human iPSC-derived Hepatic Stellate Cells Tempo-iKupffer™ – Human iPSC-derived Kupffer Cells Tempo-iLSEC™ – Human iPSC-derived Liver Sinusoidal Endothelial Cells Tempo-iHep3D™ – Human iPSC-derived […]
Experienced Life Science Operating Leader Joins Board as Company Enters New Phase SOUTH SAN FRANCISCO, Calif. — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced the appointment of Fenel Eloi to its Board of Directors (“Board”). Eloi will also serve on the Board’s Audit Committee. […]
ATLANTA — Axion BioSystems vigorously refutes a recent filing by Agilent Technologies, Inc. (NYSE: A) claiming patent infringement and false advertising. As a recognized biotechnology innovator and owner of numerous patents over 14 years, Axion BioSystems expects its competitors to respect its intellectual property rights, just as Axion respects the intellectual property rights of its […]
Pay Invoice
Latest Blogs
-
Dividends as an Indicator for Laboratory Tool Industry Companies in 2022
February 1, 2023 9:00 am
-
Improving Drug Development: Molecular Devices and Cellesce Aim to Advance the Use of Organoids
January 5, 2023 9:13 pm
-
Danaher Investor Day 2022 Showcases Big Announcements and Focuses on Cytiva
September 27, 2022 5:28 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.